Funding for this research was provided by:
NSD Co., Ltd.
Article History
Received: 3 December 2024
Accepted: 5 March 2025
First Online: 22 March 2025
Declarations
:
: K.K. received lecture fees from NSD Co., Ltd., NIPRO Co., Ltd., Medtronic Japan Co., Ltd., and LifeScan Japan K.K. Y.A. received lecture fees from NSD Co., Ltd. K.A. has no conflict of interest to disclose.
: The study protocol was reviewed and approved by the Institutional Review Board of Eiju General Hospital (date of approval,2023.7.21; approval number, 2023-3) and registered with the UMIN clinical trial registry (date of approval, 2023.9.20; approval number, UMIN 000052178). The study was also conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments and Good Clinical Practice Guideline.
: All participants were fully informed about the objectives and processes of the study and gave written informed consent prior to their participation in the study.